ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

FDA, HCFA Form Council On Biomedical Imaging.

November 10, 2000

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996